2CT7

2CT7 is a synthetic psychedelic compound belonging to the 2C family, which are characterized by a 2,5-dimethoxy substitution pattern on a phenethylamine core. Specifically, 2CT7 is known chemically as 2,5-dimethoxy-4-(trifluoromethyl)phenethylamine. It was first synthesized by chemist Alexander Shulgin and documented in his book PiHKAL (Phenethylamines I Have Known And Loved).

The pharmacological profile of 2CT7 suggests it acts as a potent agonist at serotonin receptors, particularly the 5-HT2A subtype, which is believed to mediate many of its psychedelic effects. Users have reported experiences ranging from visual alterations, synesthesia, and changes in thought patterns and emotional states. The onset, duration, and intensity of these effects are dependent on dosage and individual metabolism.

Due to its psychoactive properties, 2CT7 is considered a research chemical and is not approved for medical use. Its legal status varies by jurisdiction, with many countries classifying it as a controlled substance. Information regarding its safety profile and long-term effects in humans is limited, as it has primarily been studied in laboratory settings and through anecdotal reports.